Synthesis and Characterization of Bradykinin B2 Receptor Agonists Containing Constrained Dipeptide Mimics
Muriel Amblard, Isabelle Daffix, Gilbert Bergé et al. · Journal of Medicinal Chemistry · 1999
We have previously shown that substitution of the D-Tic-Oic dipeptide by a (3S)-[amino]-5-(carbonylmethyl)-2,3-dihydro-1, 5-benzothiazepin-4(5H)-one (D-BT) moiety in the bradykinin B(2) receptor antagonist HOE 140 resulted in a full potent and selective bradykinin B(2) receptor agonist (H-DArg-Arg-Pro-Hyp-Gly-Thi-Ser-D-BT-Arg-OH, JMV1116) exhibiting a high affinity for the human receptor (K(i) 0.7 nM). In the present study, we have investigated the effects of replacement of the D-Tic-Oic moiety by various constrained dipeptide mimetics. The resulting compounds were tested for their binding affinity toward the cloned human B(2) receptor and for their functional interaction with the bradykinin-induced contraction of isolated human umbilical vein. Subsequently, we have designed novel bradykinin B(2) receptor agonists which are likely to be resistant to enzymatic cleavage by endopeptidases and which might represent interesting new pharmacological tools. In an attempt to increase the potency of compound JMV1116, both its N-terminal part and the D-BT moiety were modified. Substitution of the D-arginine residue by a L-lysine residue led to a 10-fold more potent bradykinin B(2) ligand [compound 22 (JMV1465) (K(i) 0.07 nM)], retaining full agonist activity on human umbilical vein. Substitution of the D-BT moiety by a (3S)-[amino]-5-(carbonylmethyl)-2,3-dihydro-8-methyl-1, 5-benzothiazepin-4(5H)-one [D-BT(Me)] moiety led to compound 23 (JMV1609) which exhibited a higher agonist activity (pD(2) = 7.4) than JMV1116 (pD(2) = 6.8).
Cited by 26 works. doi:10.1021/jm9901531
Authors
- Muriel Amblard
- Isabelle Daffix
- Gilbert Bergé
- Monique Calmès
- Pierre Dodey
- Didier Pruneau
- Jean‐Luc Paquet
- Jean‐Michel Luccarini
- Pierre Bélichard
- Jean Martínez
References
- Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides
- The Preparation of Merrifield‐Resins Through Total Esterification With Cesium Salts
- Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists
- Peptides. Structure and function.
- Protected lactam-bridged dipeptides for use as conformational constraints in peptides
- Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors
- New, long‐acting, potent bradykinin antagonists
- Conformationally restricted inhibitors of angiotensin-converting enzyme. Synthesis and computations
- Angiotensin converting enzyme inhibitors: 1,5-benzothiazepine derivatives
- Practical syntheses of a novel tricyclic dipeptide mimetic based on a [6H]-azepino indoline nucleus: Application to angiotensin-converting enzyme inhibition